The Chemical Countermeasures Research Program (CCRP) is offering this grant to support transformative basic research focused on the acute and delayed effects of ultra-potent synthetic (UPS) opioid exposure. This funding opportunity aims to identify and validate critical mechanisms, signaling pathways, and potential therapeutic targets. The primary goal is to enhance understanding and develop strategies for reversing the immediate effects of overdose and the observed toxicities caused by acute UPS opioid exposure. Additionally, the grant will support in-depth mechanistic studies to elucidate persistent or delayed pathophysiological effects following such acute exposures, ultimately contributing to improved countermeasures against these dangerous substances.
Opportunity ID: 343184
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-23-056 |
| Funding Opportunity Title: | Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 18, 2022 |
| Last Updated Date: | Aug 18, 2022 |
| Original Closing Date for Applications: | Nov 19, 2024 |
| Current Closing Date for Applications: | Nov 19, 2024 |
| Archive Date: | Dec 25, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $300,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Independent school districts Special district governments Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments City or township governments Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) will support transformative research to identify and validate mechanisms, signaling pathways, and therapeutic targets, for understanding and reversing the effects of an overdose and the observed toxicities caused by acute Ultra-Potent Synthetic (UPS) opioid exposure. This FOA will also support mechanistic studies of persistent or delayed pathophysiological effects after acute exposure to UPS opioids. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-056.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 343184 Full Announcement-RFA-DA-23-056 -> RFA-DA-23-056-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00276446 | Oct 17, 2022 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277859 | Nov 01, 2022 | Nov 19, 2024 | View |
Package 1
Mandatory forms
343184 RR_SF424_5_0-5.0.pdf
343184 PHS398_CoverPageSupplement_5_0-5.0.pdf
343184 RR_OtherProjectInfo_1_4-1.4.pdf
343184 PerformanceSite_4_0-4.0.pdf
343184 RR_KeyPersonExpanded_4_0-4.0.pdf
343184 PHS398_ResearchPlan_4_0-4.0.pdf
343184 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343184 RR_Budget_3_0-3.0.pdf
343184 RR_SubawardBudget30_3_0-3.0.pdf
343184 PHS398_ModularBudget_1_2-1.2.pdf
343184 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
343184 RR_SF424_5_0-5.0.pdf
343184 PHS398_CoverPageSupplement_5_0-5.0.pdf
343184 RR_OtherProjectInfo_1_4-1.4.pdf
343184 PerformanceSite_4_0-4.0.pdf
343184 RR_KeyPersonExpanded_4_0-4.0.pdf
343184 PHS398_ResearchPlan_5_0-5.0.pdf
343184 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343184 RR_Budget_3_0-3.0.pdf
343184 RR_SubawardBudget30_3_0-3.0.pdf
343184 PHS398_ModularBudget_1_2-1.2.pdf
343184 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
